Abiopharma

Krystal Biotech to Announce Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis

Definitive Healthcare to Present at the 28th Annual Needham Growth Conference

RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs

Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Ultragenyx to Present at the 44th Annual J.P. Morgan Healthcare Conference

Bruker - Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

Mirum Pharma - Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Genelux Corporation Announces Proposed Public Offering of Common Stock

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results